US Patent 9670221 Furopyridines as bromodomain inhibitors
Patent 9670221 was granted and assigned to GlaxoSmithKline on June, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9670221 Furopyridines as bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.